Total Payments
$5,014
2024 Payments
$22.09
Companies
9
Transactions
66
Medicare Patients
9,142
Medicare Billing
$881,741
Payment Breakdown by Category
Travel$2,777 (55.4%)
Food & Beverage$1,209 (24.1%)
Research$978.59 (19.5%)
Education$49.98 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $2,777 | 9 | 55.4% |
| Food and Beverage | $1,209 | 47 | 24.1% |
| Unspecified | $978.59 | 8 | 19.5% |
| Education | $49.98 | 2 | 1.0% |
Payments by Type
General
$4,036
58 transactions
Research
$978.59
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $2,076 | 37 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,692 | 8 | $0 (2023) |
| ABBVIE INC. | $1,012 | 9 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $144.49 | 5 | $0 (2019) |
| Amgen Inc. | $22.29 | 2 | $0 (2019) |
| Merck Sharp & Dohme LLC | $22.09 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $21.91 | 2 | $0 (2018) |
| Amarin Pharma Inc. | $11.91 | 1 | $0 (2020) |
| Radius Health, Inc. | $11.03 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.09 | 1 | Merck Sharp & Dohme LLC ($22.09) |
| 2023 | $1,726 | 9 | Bayer Healthcare Pharmaceuticals Inc. ($1,692) |
| 2021 | $5.23 | 1 | PFIZER INC. ($5.23) |
| 2020 | $33.54 | 4 | Amarin Pharma Inc. ($11.91) |
| 2019 | $1,074 | 17 | AbbVie, Inc. ($978.59) |
| 2018 | $1,254 | 20 | PFIZER INC. ($1,099) |
| 2017 | $899.15 | 14 | PFIZER INC. ($899.15) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: VACCINE | ||||||
| 04/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $116.84 | General |
| 04/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $84.42 | General |
| 04/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $75.42 | General |
| 04/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $34.28 | General |
| 04/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $34.28 | General |
| 04/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $1,011.25 | General |
| 04/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Travel and Lodging | In-kind items and services | $210.90 | General |
| 04/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 01/24/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2021 | PFIZER INC. | PREMARIN (Drug), PREMARIN, COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: WOMENS HEALTH | ||||||
| 03/05/2020 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: Endocrinology | ||||||
| 02/18/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: Cardiovascular | ||||||
| 02/13/2020 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $4.95 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/09/2020 | PFIZER INC. | CHANTIX (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/21/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Bone Health | ||||||
| 09/05/2019 | PFIZER INC. | EUCRISA (Drug) | Education | In-kind items and services | $34.95 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $4.38 | General |
| Category: DERMATOLOGY | ||||||
| 08/30/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $33.76 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 08/30/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $31.82 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
| 08/01/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: DERMATOLOGY | ||||||
| 06/20/2019 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 05/28/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/21/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.84 | General |
| Category: Bone Health | ||||||
| 04/07/2019 | AbbVie, Inc. | Androgel (Drug) | — | In-kind items and services | $576.71 | Research |
| Study: M16-100 • Category: Endocrinology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M16-100 | AbbVie, Inc. | $978.59 | 8 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,696 | 3,196 | $420,885 | $182,561 |
| 2022 | 17 | 2,315 | 4,622 | $558,635 | $227,487 |
| 2021 | 20 | 2,628 | 5,604 | $625,502 | $267,368 |
| 2020 | 24 | 2,503 | 5,467 | $579,076 | $204,324 |
Total Patients
9,142
Total Services
18,889
Medicare Billing
$881,741
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 444 | 444 | $151,848 | $58,228 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 361 | 647 | $102,226 | $37,810 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 241 | 358 | $77,328 | $28,607 | 37.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,020 | $29,580 | $18,618 | 62.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 54 | 54 | $18,026 | $14,945 | 82.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 159 | 159 | $13,833 | $11,880 | 85.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 161 | 161 | $7,245 | $4,991 | 68.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,068 | $2,017 | 49.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 58 | 58 | $2,610 | $1,789 | 68.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 31 | 37 | $5,143 | $1,394 | 27.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,274 | $572.42 | 44.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 21 | 85 | $2,550 | $387.02 | 15.2% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 11 | 12 | $1,332 | $343.79 | 25.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $480.00 | $303.36 | 63.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 29 | $1,392 | $270.25 | 19.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 57 | 73 | $1,168 | $248.93 | 21.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 17 | $782.00 | $157.14 | 20.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 504 | 1,000 | $216,000 | $76,903 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 446 | 446 | $152,532 | $58,940 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 345 | 508 | $80,264 | $29,348 | 36.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 18 | 1,500 | $43,500 | $25,086 | 57.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 184 | 186 | $16,092 | $13,032 | 81.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 375 | 375 | $11,250 | $6,987 | 62.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 189 | 191 | $8,595 | $5,736 | 66.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 27 | 27 | $9,153 | $4,234 | 46.3% |
About Dr. Brad Frandsen, MD
Dr. Brad Frandsen, MD is a Family Medicine healthcare provider based in Port Orchard, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700820966.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brad Frandsen, MD has received a total of $5,014 in payments from pharmaceutical and medical device companies, with $22.09 received in 2024. These payments were reported across 66 transactions from 9 companies. The most common payment nature is "Travel and Lodging" ($2,777).
As a Medicare-enrolled provider, Frandsen has provided services to 9,142 Medicare beneficiaries, totaling 18,889 services with total Medicare billing of $881,741. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Port Orchard, WA
- Active Since 06/16/2006
- Last Updated 08/29/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1700820966
Products in Payments
- Androgel (Drug) $978.59
- FARXIGA (Drug) $109.61
- LYRICA (Drug) $101.34
- EUCRISA (Drug) $44.48
- CHANTIX (Drug) $40.07
- BYDUREON (Drug) $34.88
- UBRELVY (Drug) $33.80
- EVENITY (Biological) $22.29
- GARDASIL (Biological) $22.09
- ANORO (Drug) $21.91
- Vascepa (Drug) $11.91
- Tymlos (Biological) $11.03
- PREMARIN (Drug) $5.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Port Orchard
Christine Lomotan, M.d, M.D
Family Medicine — Payments: $25,916
Family Medicine $25,916
Dr. Erin Dawson, Md, MD
Family Medicine — Payments: $2,472
Family Medicine $2,472
Dr. Michael Mccord, M.d, M.D
Family Medicine — Payments: $2,188
Family Medicine $2,188
Dr. Christopher Quarles, Md, MD
Family Medicine — Payments: $641.14
Family Medicine $641.14
Dr. Samay Jain, M.d, M.D
Family Medicine — Payments: $522.73
Family Medicine $522.73
Melissa Meyer, M.d, M.D
Family Medicine — Payments: $252.71
Family Medicine $252.71